The field of psychedelic research lost one of the greats on October 16, 2023. Join us in celebrating the life and contribution of Roland Griffiths.
Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international...
The Brain & Behavior Research Foundation today announced it is awarding $10.2 million in Young Investigator Grants to 150 promising early career...
“The hallmark feature of the mystical experience, that we can now occasion with high probability, is the sense of the interconnectedness of all things...
-Radix Motion granted U.S. Patent No. 11,806,162 for its movement data and AI technology -Issuing date for patent is set for November 7th, 2023 “It’s...
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Jennifer Chesak, the author of The Psilocybin Handbook for Women. Jennifer...
Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF)has gotten the green light for its deal with Cybin Inc. (NYSE American:CYBN) (NEO:CYBN). Small Pharma announced...
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) CEO Joshua Bartch speaks to Thomas Warner from Proactive London about the biotechnology company’s...
Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth. The post Spravato Sales Lead J&J...
-The trial is being conducted at the University of Alabama at Birmingham (UAB) under noted psychedelic researcher Dr. Peter Hendricks- -This exploratory...